Acquired idiopathic torsion dystonia
disease diseaseOn this page
Also known as idiopathic non-familial dystonianon-Familial Idiopathic dystonia
Summary
Acquired idiopathic torsion dystonia (MONDO:0044817) is a disease. A subtype of idiopathic torsion dystonia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | acquired idiopathic torsion dystonia |
| Mondo ID | MONDO:0044817 |
| NCIT | C35438 |
| SNOMED CT | 230321007 |
| UMLS | C0393601 |
| MedGen | 98279 |
| GARD | 0027977 |
| Is cancer (heuristic) | no |
Also known as: acquired idiopathic torsion dystonia · idiopathic non-familial dystonia · non-Familial Idiopathic dystonia
Disease family
This is a subtype of idiopathic torsion dystonia. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › nervous system disorder › movement disorder › extrapyramidal and movement disease › dystonic disorder › idiopathic torsion dystonia › acquired idiopathic torsion dystonia
Related subtypes (1): familial idiopathic torsion dystonia
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.